Uganda's healthcare system has a profile that surprises many first-time observers. A country with a GDP per capita below USD 1,000 has produced internationally recognised clinical research on HIV, malaria, and tuberculosis; it has deployed electronic health records to more facilities than most of its regional neighbours; and it runs one of Africa's more extensive community health worker programmes. The system faces chronic underfunding, a severe workforce shortage, and persistent infrastructure gaps, but its research capacity, disease burden profile, and growing digital infrastructure make it an important geography for pharmaceutical sponsors, CROs, and health organisations working in East Africa. This profile maps the Uganda healthcare system from its structural foundations to its data infrastructure and research potential.
Overview of Uganda's healthcare system
The Uganda healthcare system is organised by the Ministry of Health (MoH) under a four-tier service delivery framework. The National Referral Hospitals sit at the top, followed by Regional Referral Hospitals, General Hospitals and Health Centre IVs, and a large network of Health Centres I, II, and III at sub-county and village level.
Key headline indicators:
- Population: approximately 45.9 million (Uganda National Population and Housing Census, May 2024)
- Life expectancy at birth: approximately 63.6 years (World Bank 2022)
- Under-5 mortality rate: 38.8 per 1,000 live births (UNICEF 2023)
- Physician density: approximately 0.15 per 1,000 population (WHO Global Health Observatory)
- Total health expenditure as share of GDP: approximately 5.3 percent (WHO 2021)
- HIV prevalence: approximately 5.1 percent among adults aged 15 to 49 (UNAIDS 2022 estimate)
- Malaria incidence: 268 cases per 1,000 population at risk (WHO/World Bank 2022)
The country's health system is heavily dependent on donor financing. External sources (primarily PEPFAR, the Global Fund, USAID, and bilateral aid) account for an estimated 40 to 50 percent of total health spending, according to the Uganda National Health Accounts. Government budget allocations to health have consistently fallen short of the Abuja Declaration target of 15 percent of government expenditure, typically running at 6 to 9 percent.
Health system structure: from national to community level
Hospitals in Uganda span a spectrum of capacity and ownership. At the national level, Mulago National Referral Hospital in Kampala is the country's largest public hospital, with approximately 1,600 beds and tertiary care capacity across most specialties. It is affiliated with Makerere University College of Health Sciences, the country's main medical training institution.
Regional Referral Hospitals, one in each of 14 designated regions, provide secondary care including surgery, obstetrics, internal medicine, and paediatrics. Facilities including Mbarara, Mbale, Gulu, Fort Portal, Jinja, and Arua Regional Referral Hospitals serve as the main referral points for large rural populations and are important sites for clinical research programmes.
General Hospitals and Health Centre IVs, the third tier, number approximately 200 public facilities and provide inpatient care, basic surgery, and laboratory services for district-level populations. Health Centres III (sub-county level) and Health Centres II (parish level) provide outpatient, maternal health, and immunisation services. Village Health Teams (VHTs) at Health Centre I level are Uganda's community health worker cadre: trained lay workers who conduct household-level health promotion, referrals, and basic treatment.
As of 2022/2023, Uganda's health system comprised approximately 8,400 total health facilities (public and private). The government operated approximately 3,450 facilities (41% of the total), while the private sector, including private-not-for-profit (PNFP) facilities operated by faith-based organisations (predominantly Uganda Catholic Medical Bureau and Uganda Protestant Medical Bureau), accounts for approximately 35 to 40 percent of service delivery.
The most significant workforce constraint is the doctor shortage. Uganda has approximately 7,000 registered doctors for a population of approximately 46 million, a ratio of around 0.15 per 1,000, far below the WHO recommended minimum of 1 per 1,000. Nurses and midwives are more numerous but still insufficient relative to population, and their distribution skews heavily toward urban areas and private facilities.
Disease burden and public health priorities
Uganda's disease burden reflects the dual challenge facing many sub-Saharan African countries: high infectious disease burden alongside growing non-communicable disease prevalence.
HIV remains the most significant single disease challenge. With a 5.1 percent adult prevalence rate, Uganda has one of the highest HIV burdens in East Africa. Approximately 1.4 million Ugandans were living with HIV as of 2023, according to UNAIDS estimates. Treatment coverage has improved substantially: approximately 1.3 million were on antiretroviral therapy as of 2022. Uganda was one of the first countries in the world to achieve significant HIV incidence reductions through behavioural change programmes in the late 1980s and 1990s, and it has remained a global reference point for HIV programme implementation.
Malaria is endemic across most of the country. At 268 cases per 1,000 population at risk, Uganda has one of the highest malaria transmission rates in Sub-Saharan Africa. It is a leading cause of outpatient visits, inpatient admissions, and child mortality. The National Malaria Control Division has scaled insecticide-treated net distribution and indoor residual spraying programmes, but transmission reduction has been challenging in high-intensity zones.
Tuberculosis incidence is estimated at approximately 198 per 100,000 population (WHO 2022), with HIV coinfection complicating treatment in a significant proportion of cases. The Uganda National TB and Leprosy Programme runs a network of TB diagnostic and treatment services, with PEPFAR and Global Fund support.
Maternal and reproductive health indicators remain concerning. The maternal mortality ratio was approximately 189 per 100,000 live births according to the 2022/23 Uganda Demographic and Health Survey (UDHS), down from 336 per 100,000 recorded in the 2016 UDHS. Teenage pregnancy rates are among the highest in East Africa, at approximately 25 percent of women aged 15 to 19.
Non-communicable diseases are growing: hypertension prevalence in Ugandan adults is estimated at approximately 26 to 29 percent nationally, with higher rates in urban areas. Sickle cell disease has a high carrier frequency in Uganda's population, with approximately 13 to 20 percent of the population carries the sickle cell trait in some regions, making Uganda important for sickle cell research.
Digital health in Uganda: EMR and data systems
Digital health in Uganda has been shaped primarily by HIV programme requirements, donor investment, and a small but active health technology sector.
The national health information system is built on DHIS2, deployed across thousands of facilities for aggregate reporting. Uganda is one of the longest-running DHIS2 implementations in Sub-Saharan Africa, with national aggregate data extending back over 15 years. The system covers all levels of the public health facility hierarchy and provides national, regional, district, and facility-level reporting.
OpenMRS-based patient-level EMR systems have been deployed primarily in HIV clinics. The Uganda EMR (UgandaEMR) programme, coordinated by the MoH with PEPFAR support, has deployed OpenMRS at hundreds of PEPFAR-supported HIV facilities. UgandaEMR captures patient demographics, HIV diagnosis, ART regimen, viral load results, and clinical visits, generating one of the continent's larger HIV longitudinal datasets.
DHIS2 Tracker has been deployed for integrated disease surveillance, maternal and child health tracking, and immunisation management. The Uganda Virus Research Institute (UVRI) runs real-time surveillance systems for viral haemorrhagic fevers and other priority pathogens, linked into the national surveillance network.
The Makerere University Joint AIDS Programme (MJAP) and the Infectious Diseases Institute (IDI) at Makerere have contributed significantly to EMR implementation and health data quality improvement in Uganda. IDI in particular has been a leading implementer of clinical informatics systems at Mulago and regional referral hospitals.
Private-sector digital health adoption is concentrated in Kampala and a few other urban centres. A growing number of private clinics use commercial EMR systems from Kenyan and Nigerian vendors, though standardisation and interoperability with government systems remain limited.
Health data infrastructure and research potential
Health data in Uganda encompasses several distinct layers that collectively represent significant research value.
HIV longitudinal data from UgandaEMR-connected facilities covers hundreds of thousands of patients in care, with data on treatment initiation, viral load, CD4 count, opportunistic infections, and clinical outcomes. This dataset is the most complete long-term HIV patient dataset in Uganda and has been used in multiple published research studies.
Population-based surveillance from the Uganda Demographic and Health Survey (UDHS), conducted every five years, provides nationally representative data on health behaviours, outcomes, and demographic indicators. The most recent survey (2021) provides a benchmark against which facility data can be calibrated.
Research cohort data from Uganda's major research institutions represents a distinct and highly curated data resource. The MRC/UVRI and LSHTM Uganda Research Unit in Entebbe maintains cohorts for HIV, TB, malaria, and other infectious diseases that have been followed for decades. The Rakai Community Cohort Study, initiated in 1994, is one of the world's longest-running HIV cohort studies and has contributed foundational research on HIV transmission and prevention.
Kapsule has integrated records from Ugandan health facilities into its pan-African dataset, enabling feasibility analysis and real-world evidence generation that spans Uganda alongside nine other African countries.
The parallel between Uganda and Rwanda is instructive. Both are small landlocked East African countries with strong government health sector coordination, high HIV programme investment, and above-average research capacity relative to income level. Rwanda has achieved higher overall EMR coverage and more integrated national data systems; Uganda has larger population scale and a longer established research infrastructure through Makerere. Kenya provides the regional contrast: larger economy, more developed EMR ecosystem, but similar infectious disease research strengths.
Clinical research capacity
Uganda's clinical research capacity is concentrated at a small number of high-performing institutions with international partnerships.
Makerere University College of Health Sciences is the primary medical training institution and the anchor of Uganda's research ecosystem. Through its affiliated institutes (MJAP, IDI, the Child Health and Development Centre) it has participated in landmark HIV, TB, malaria, and reproductive health trials.
UVRI (Uganda Virus Research Institute), a government research institute with close links to the MRC (Medical Research Council, UK), has conducted long-term cohort studies, vaccine trials, and outbreak response research. Its BSL-3 capacity and virology expertise make it a key partner for pathogen research.
Uganda Cancer Institute (UCI), the national oncology referral centre, has been developing clinical trial capacity in haematological cancers and is an emerging site for oncology research in East Africa. Sickle cell disease research has been particularly active given the high carrier prevalence.
The regulatory framework for clinical trials is managed by the National Drug Authority (NDA), which issues Clinical Trial Authorisations. The Uganda National Council for Science and Technology (UNCST) and institutional ethics review boards (including Makerere's IRB) provide ethics oversight. NDA approval timelines typically run 3 to 6 months for standard applications. The ethics review process adds additional time, making total regulatory timelines comparable to Kenya and Rwanda but shorter than Nigeria for multi-site studies.
Opportunities for pharma, CROs, and health organisations
Uganda's disease burden and research infrastructure create specific opportunities for external organisations:
HIV and TB. Uganda's high HIV prevalence, extensive ART programme, and research institutions make it an important site for HIV treatment optimisation, prevention, and cure research. TB coinfection research is similarly well-positioned.
Sickle cell disease. High sickle cell trait prevalence in Ugandan populations, combined with the IDI and UCI's growing capacity, creates an underutilised platform for sickle cell treatment trials and natural history studies.
Malaria. Uganda's high transmission intensity makes it one of the world's most valuable settings for malaria drug and vaccine trials. The UVRI and Makerere have conducted Phase I and Phase II malaria vaccine trials with WHO support.
NCD research. The growing hypertension and diabetes burden in Uganda, with relatively young and treatment-naive patient populations, provides opportunities for cardiovascular and metabolic disease studies in a population biologically distinct from Western cohorts.
Real-world evidence. Uganda's HIV longitudinal datasets, combined with improving general health EMR coverage, provide a platform for real-world evidence studies on treatment effectiveness, drug safety, and health outcomes in an East African population.
Kapsule provides access to structured, de-identified health records covering over 75 million patients across 9 African countries. Contact our team to discuss how Ugandan patient data can support your clinical research, market entry, or public health programme.
This article is intended for informational purposes only and does not constitute legal, medical, or regulatory advice. Readers should obtain independent professional counsel for their specific circumstances.